BBA
KRYS icon

Baader Bank Aktiengesellschaft’s Krystal Biotech KRYS Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$669K Buy
+1,800
New +$538K 0.05% 231
2026
Q1 		– Sell
-3,163
Closed -$769K – 494
2025
Q4 		$769K Buy
+3,163
New +$666K 0.05% 208

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baader Bank Aktiengesellschaft's KRYS Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft opened a new position in Krystal Biotech (KRYS) in Q2 2026: 1,800 shares worth $669K. The stake represents 0.05% of the portfolio and ranks #231 among its holdings. This is a return to the name: Baader Bank Aktiengesellschaft previously reported a position in KRYS as recently as Q4 2025.

Baader Bank Aktiengesellschaft first reported a position in KRYS in Q4 2025 and has held it in 2 quarters since. The position peaked at $769K in Q4 2025. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 1,800 shares of Krystal Biotech worth $669K as of Q2 2026.
  • Krystal Biotech was a new Baader Bank Aktiengesellschaft position in Q2 2026.
  • Krystal Biotech made up 0.05% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #231 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Krystal Biotech in Q4 2025 and has held it in 2 quarters since.
  • Baader Bank Aktiengesellschaft's Krystal Biotech position peaked at $769K in Q4 2025.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.